Combination of Nicorandil and Beta-Adrenergic Receptor Blockers in Patients with Coronary Artery Disease: A Real-World Observational Study

Combination of Nicorandil and Beta-Adrenergic Receptor Blockers in Patients with Coronary Artery Disease: A Real-World Observational Study

Background The effect of combined nicorandil and beta-adrenergic receptor blockers (BBs) compared with that of BBs alone on long-term clinical outcomes in patients with coronary artery disease (CAD) remains undetermined. Methods A multicenter retrospective cohort study was performed. Adult patients...

Full description

Bibliographic Details
Main Authors: Jia Cheng MD, PhD, Lin Qiu MS, Zixuan Zhang MD, Na Li MD, Hongyang Shu MD, PhD, Zhichao Xiao MD, PhD, Ning Zhou MD, PhD
Format: Article
Language:English
Published: SAGE Publishing 2023-09-01
Series:Journal of Cardiovascular Pharmacology and Therapeutics
Online Access:https://doi.org/10.1177/10742484231197559

Internet

https://doi.org/10.1177/10742484231197559

Similar Items